Polaris AI Pharma Corp. (KOSDAQ:041910)
6,460.00
-180.00 (-2.71%)
At close: Feb 13, 2026
Polaris AI Pharma Market Cap
Polaris AI Pharma has a market cap or net worth of 85.81 billion as of February 13, 2026. Its market cap has increased by 11.57% in one year.
Market Cap
85.81B
Enterprise Value
n/a
Revenue
63.94B
Ranking
n/a
PE Ratio
76.25
Stock Price
6,460.00
Market Cap Chart
Since May 17, 2004, Polaris AI Pharma's market cap has increased from 10.75B to 85.81B, an increase of 698.24%. That is a compound annual growth rate of 10.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 85.81B | 3.69% |
| Dec 30, 2025 | 82.76B | 16.23% |
| Dec 30, 2024 | 71.20B | -11.66% |
| Dec 28, 2023 | 80.59B | -2.68% |
| Dec 29, 2022 | 82.81B | -26.15% |
| Dec 30, 2021 | 112.13B | -24.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BL Pharmtech | 111.52B |
| H.PIO | 99.27B |
| Sam-A Pharm. | 98.45B |
| Ahn-Gook Pharmaceutical | 98.42B |
| Daehan Nupharm | 95.02B |
| Hwail Pharmaceutical | 90.95B |
| Sinsin Pharmaceutical | 89.96B |
| GL Pharm Tech | 85.30B |